Archives     Advertise     Editorial Calendar     Subscribe     Contact Us    


Articles related to Ifetroban


Ifetroban for Treating DMD-Associated Cardiomyopathy
Ifetroban for Treating DMD-Associated Cardiomyopathy

Following successful preclinical trials and FDA funding, Cumberland Pharmaceuticals is preparing to launch a new Phase II trial of ifetroban to treat cardiomyopathy in Duchenne Muscular Dystrophy patients.

more
From Clinical Trial to Commercialization
From Clinical Trial to Commercialization

The road to drug development and approval is long and expensive. Cumberland Pharmaceutical CEO A.J. Kazimi offers an inside look at the process.

more
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: